Mesoblast Ltd (MSB):企業の財務・戦略的SWOT分析

◆英語タイトル:Mesoblast Ltd (MSB) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH61698FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年2月
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Mesoblast Ltd (MSB) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Mesoblast Ltd (Mesoblast) is a regenerative medicine company that develops regenerative cell-based products. Its most advanced candidate remestemcel-L is in registration phase under the brand name RYONCIL for the treatment of pediatric steroid-refractory acute graft versus host disease (SR-aGVHD).

Mesoblast Ltd Key Recent Developments

Jan 29,2021: Mesoblast operational and financial highlights for quarter ended December 31, 2020
Nov 23,2020: Mesoblast signs ARDS therapy development deal with Novartis
Nov 19,2020: Mesoblast: Operational and financial results for the period ended September 30, 2020
Aug 26,2020: Mesoblast reports substantial operational progress and financial results for the year ended June 30, 2020
Jul 24,2020: Executive leadership expanded ahead of first potential U.S. product launch

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Mesoblast Ltd – Key Facts
Mesoblast Ltd – Key Employees
Mesoblast Ltd – Key Employee Biographies
Mesoblast Ltd – Major Products and Services
Mesoblast Ltd – History
Mesoblast Ltd – Company Statement
Mesoblast Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Mesoblast Ltd – Business Description
Business Segment: Commercialization Revenue
Performance
Business Segment: Interest Revenue
Performance
Business Segment: Milestone Revenue
Performance
R&D Overview
Mesoblast Ltd – Corporate Strategy
Mesoblast Ltd – SWOT Analysis
SWOT Analysis – Overview
Mesoblast Ltd – Strengths
Mesoblast Ltd – Weaknesses
Mesoblast Ltd – Opportunities
Mesoblast Ltd – Threats
Mesoblast Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Mesoblast Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Mesoblast Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Mesoblast Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jan 29, 2021: Mesoblast operational and financial highlights for quarter ended December 31, 2020
Nov 23, 2020: Mesoblast signs ARDS therapy development deal with Novartis
Nov 19, 2020: Mesoblast: Operational and financial results for the period ended September 30, 2020
Aug 26, 2020: Mesoblast reports substantial operational progress and financial results for the year ended June 30, 2020
Jul 24, 2020: Executive leadership expanded ahead of first potential U.S. product launch
May 27, 2020: Mesoblast reports strong financial position and substantial operational progress for the period ended March 31, 2020
Apr 29, 2020: Mesoblast financial and operational highlights for the quarter ended March 31, 2020
Feb 27, 2020: Mesoblast reports financial results and corporate highlights for first half ended December 31, 2019
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Mesoblast Ltd, Key Facts
Mesoblast Ltd, Key Employees
Mesoblast Ltd, Key Employee Biographies
Mesoblast Ltd, Major Products and Services
Mesoblast Ltd, History
Mesoblast Ltd, Other Locations
Mesoblast Ltd, Subsidiaries
Mesoblast Ltd, Key Competitors
Mesoblast Ltd, Ratios based on current share price
Mesoblast Ltd, Annual Ratios
Mesoblast Ltd, Annual Ratios (Cont...1)
Mesoblast Ltd, Interim Ratios
Mesoblast Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Mesoblast Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Mesoblast Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Mesoblast Ltd (MSB):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CohBar Inc (COB.U):企業の財務・戦略的SWOT分析
    Summary CohBar Inc (CohBar) is a developer of mitochondria based therapeutics. The company develops a class of drugs to treat a wide range of diseases associated with aging and metabolic dysfunction such as non-alcoholic steatohepatitis, obesity, type 2 diabetes, cancer, cardiovascular disease and C …
  • Standard Bank Group Ltd (SBK):企業の財務・戦略的SWOT分析
    Standard Bank Group Ltd (SBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Sinopharm Group Co Limited:企業の戦略・SWOT・財務分析
    Sinopharm Group Co Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopharm Group Co Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • First Asset Investment Management Inc:企業の戦略的SWOT分析
    First Asset Investment Management Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • SK Chemicals Co Ltd (006120):企業の財務・戦略的SWOT分析
    Summary SK Chemicals Co Ltd (SK Chemicals) is a provider of chemical and pharmaceutical products. The company offers pharmaceutical drugs to treat erectile dysfunction, arthritis, peptic ulcer, gastroesophageal reflux disease (GERD), cancer and to improve blood circulation. It manufactures green che …
  • Pioneer Energy Services Corp (PESX):企業の財務・戦略的SWOT分析
    Pioneer Energy Services Corp (PESX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Flipkart Internet Private Limited:企業のM&A・事業提携・投資動向
    Flipkart Internet Private Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Flipkart Internet Private Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Sports Direct International Plc:企業のM&A・事業提携・投資動向
    Sports Direct International Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sports Direct International Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Net Insight AB (NETI B):企業の財務・戦略的SWOT分析
    Net Insight AB (NETI B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • TSUM Trading House:企業の戦略的SWOT分析
    TSUM Trading House - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Interconexion Electrica SA ESP (ISA):企業の財務・戦略的SWOT分析
    Interconexion Electrica SA ESP (ISA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Real Matters Inc (REAL):企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • General Electric Company:企業の戦略・SWOT・財務情報
    General Electric Company - Strategy, SWOT and Corporate Finance Report Summary General Electric Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Entegris Inc (ENTG):企業の財務・戦略的SWOT分析
    Summary Entegris Inc (Entegris) is a manufacturer and supplier of micro contamination control products, specialty chemicals, and advanced materials handling solutions. The company offers products for wafer shipping and processing; gas filtration and purification; mask and reticle handling; hard disk …
  • Aurora Energy Pty Ltd:企業の戦略的SWOT分析
    Aurora Energy Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Banca Carige SpA (CRG):企業の財務・戦略的SWOT分析
    Banca Carige SpA (CRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • PanAust Ltd:企業の戦略・SWOT・財務分析
    PanAust Ltd - Strategy, SWOT and Corporate Finance Report Summary PanAust Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Vietnam Electricity Construction Joint – Stock Corp (VNE):電力:M&Aディール及び事業提携情報
    Summary Vietnam Electricity Construction Joint - Stock Corp (VNECO) is a diversified company. The company operates through its business divisions such as electricity construction, industrial production, delivery of equipment, investment power, and consulting services. Its electricity construction di …
  • Rowan Companies plc:企業の戦略・SWOT・財務情報
    Rowan Companies plc - Strategy, SWOT and Corporate Finance Report Summary Rowan Companies plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Under Armour, Inc.:企業の戦略・SWOT・財務情報
    Under Armour, Inc. - Strategy, SWOT and Corporate Finance Report Summary Under Armour, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆